Arca Biopharma Inc (ABIO)

HEALTH CARE: PHARMACEUTICALS
SIC: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

11080 CIRCLEPOINT ROAD WESTMINSTER, CO 80020

Arca Biopharma discovers, develops and commercializes novel products for acute cardiovascular indications and cancer. As of March 2005, the company had three drug candidates in clinical trials, including its lead candidate, alfimeprase, a thrombolytic agent.

Data as of 2021-01-23
Market Cap43.438 Million Shares Outstanding9.321 Million Avg 30-day Volume606.903 Thousand
P/E Ratio-1.8 Dividend Yield EPS-2.58
Price/Sales Price cash flow ratio Price free cash flow ratio-9.2
Book Value5.41 Price to Tangible Book0.86 Alpha-0.04
Short Interest Ratio % Short Interest to Float R-squared0.106909
BETA2.8033 52-week High/Low22.0 / 2.21 Stddev0.377264
View SEC Filings from ABIO instead.
Q3 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 16 9 77.78% 4 (0.26%) 2 (0.13%) 100.0%
13F shares: 412.187 Thousand 135.831 Thousand 203.46% 66.722 Thousand 103.191 Thousand -35.34%
% Ownership 6.98 2.3002 203.45% 1.1299 1.7474 -35.34%
New Positions: 8 3
Increased Positions 3 1 200.0%
Closed Positions 1 4 -75.0% 1
Reduced Positions 2 3 -33.33% 1 2 -50.0%
Total Calls 0
Total Puts 0
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ABIO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ABIO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

10 Thousand total shares from 1 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GRAIS LINDA

  • Director
0 2021-01-12 1

WOOSLEY RAYMOND L.

  • Director
0 2021-01-12 1

CONWAY ROBERT E

  • Director
  • CHAIRMAN OF THE BOARD
30,000 2021-01-12 5

MITCHELL DANIEL J

  • Director
611 2021-01-12 1

HOVE ANDERS D

  • Director
0 2021-01-12 1

OZEROFF CHRISTOPHER DAVID S.V.P., GENERAL COUNSEL

  • Officer
970 2020-12-21 1

BRISTOW MICHAEL R PRES. & CHIEF EXECUTIVE OFFIC

  • Officer
  • Director
4,808 2020-12-21 1

SELBY BRIAN L. VP, FINANCE

  • Officer
0 2020-12-21 1

KEUER THOMAS A CHIEF OPERATING OFFICER

  • Officer
730 2020-12-21 1

MAKOWER JOSHUA

  • 10% Owner
No longer subject to file 2018-02-26 0

SAKODA JON

  • 10% Owner
No longer subject to file 2018-02-26 0

GROWTH EQUITY OPPORTUNITIES IV, LLC

NEW ENTERPRISE ASSOCIATES 15, L.P.

NEA PARTNERS 15, L.P.

NEA 15 GP, LLC

  • 10% Owner
No longer subject to file 2018-02-26 0

SONSINI PETER W.

  • 10% Owner
No longer subject to file 2018-02-26 0

BARRIS PETER J

  • 10% Owner
No longer subject to file 2018-02-26 0

BASKETT FOREST

  • 10% Owner
No longer subject to file 2018-02-26 0

MOTT DAVID M

  • 10% Owner
No longer subject to file 2018-02-26 0

FLORENCE ANTHONY A. JR.

  • 10% Owner
No longer subject to file 2018-02-26 0

SANDELL SCOTT D

  • 10% Owner
No longer subject to file 2018-02-26 0

VISWANATHAN RAVI

  • 10% Owner
No longer subject to file 2018-02-26 0

VENROCK HEALTHCARE CAPITAL PARTNERS LP

VHCP CO-INVESTMENT HOLDINGS, LLC

VHCP MANAGEMENT, LLC

VENROCK HEALTHCARE CAPITAL PARTNERS II, L.P.

VHCP CO-INVESTMENT HOLDINGS II, LLC

VHCP MANAGEMENT II, LLC

KOH BONG Y

SHAH NIMISH P

  • 10% Owner
No longer subject to file 2018-02-26 0

VENROCK HEALTHCARE CAPITAL PARTNERS LP

VENROCK HEALTHCARE CAPITAL PARTNERS II, L.P.

VHCP CO-INVESTMENT HOLDINGS, LLC

VHCP CO-INVESTMENT HOLDINGS II, LLC

KOH BONG Y

HOVE ANDERS D

VHCP MANAGEMENT, LLC

VHCP MANAGEMENT II, LLC

  • 10% Owner
10,789,324 2015-06-16 0

WELLER HARRY R

  • 10% Owner
10,221,465 2015-06-16 0

KOLLURI KRISHNA KITTU

  • 10% Owner
10,221,465 2015-06-16 0

MCCORMACK RILEY

  • 10% Owner
No longer subject to file 2015-01-14 0

WHEELER PATRICK M CHIEF FINANCIAL OFFICER

  • Officer
101,510 2014-09-18 0

ZABRISKIE JOHN L

  • Director
0 2013-09-17 0

ATLAS VENTURE FUND VII L P

ATLAS VENTURE ASSOCIATES VII, L.P.

  • 10% Owner
1,579,542 2012-10-25 0

FORMELA JEAN FRANCOIS

  • Director
  • 10% Owner
1,579,542 2012-10-22 0

BREWER RICHARD B

  • Director
0 2012-02-10 0

SOBEL BURTON E

  • Director
0 2012-02-10 0

ATLAS VENTURE FUND VII L P

  • 10% Owner
1,337,612 2010-03-29 0

PENDERGAST MARY K

  • Director
0 2010-02-05 0

FREYTAG J WILLIAM

  • Director
0 2010-02-05 0

LOVE TED W

  • Director
0 2010-02-05 0

LOWE DAVID GEORGE

  • Director
No longer subject to file 2009-07-17 0

FALBERG KATHRYN E CFO AND COO

  • Officer
0 2009-06-25 0

SKYLINE VENTURE PARTNERS QUALIFIED PURCHASER FUND IV L P

  • FORMER 10% OWNER
No longer subject to file 2009-06-11 0

BOULDER VENTURES IV ANNEX LP

BOULDER VENTURES IV LP

BV PARTNERS IV, L.L.C.

FIDLER JOSH E

JONES ANDREW E

LEFKOFF KYLE

MACKS LAWRENCE M

ROSHKO PETER

  • 10% Owner
No longer subject to file 2009-04-06 0

ST LAURENT RANDALL EVP COMMERCIAL OPERATIONS

  • Officer
0 2009-01-27 0

BENDEKGEY E LEE CFO AND TREASURER

  • Officer
1,502 2008-12-31 0

GAVIN JAMES R III

  • Director
0 2008-06-04 0

PERRY MARK L

  • Director
0 2008-06-04 0

POPOVITS KIMBERLY J

  • Director
0 2008-06-04 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

GRAIS LINDA - Director

2021-01-13 19:06:01 -0500 2021-01-12 A 12,000 a 12,000 direct

MITCHELL DANIEL J - Director

2021-01-13 19:05:18 -0500 2021-01-12 A 12,000 a 12,000 direct

WOOSLEY RAYMOND L. - Director

2021-01-13 19:06:34 -0500 2021-01-12 A 12,000 a 12,000 direct

HOVE ANDERS D - Director

2021-01-13 19:07:09 -0500 2021-01-12 A 12,000 a 12,000 direct

CONWAY ROBERT E - Director CHAIRMAN OF THE BOARD

2021-01-13 19:04:38 -0500 2021-01-12 A 12,000 a 12,000 direct

BRISTOW MICHAEL R - Director - Officer PRES. & CHIEF EXECUTIVE OFFIC

2020-12-23 16:15:08 -0500 2020-12-21 A 190,000 a 190,000 direct

KEUER THOMAS A - Officer CHIEF OPERATING OFFICER

2020-12-23 16:47:42 -0500 2020-12-21 A 70,000 a 70,000 direct

OZEROFF CHRISTOPHER DAVID - Officer S.V.P., GENERAL COUNSEL

2020-12-23 16:15:11 -0500 2020-12-21 A 55,000 a 55,000 direct

SELBY BRIAN L. - Officer VP, FINANCE

2020-12-23 16:15:08 -0500 2020-12-21 A 55,000 a 55,000 direct

CONWAY ROBERT E - Director CHAIRMAN OF THE BOARD

2020-12-21 16:15:11 -0500 2020-12-18 P 10,000 $4.16 a 30,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments